Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Preimplantation Genetic Screening (PGS) Technology Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Medical Care / Global Preimplantation Genetic Screening (PGS) Technology Market

Global Preimplantation Genetic Screening (PGS) Technology Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Medical Care Dec 2021 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Buy Now Free Analysis
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Preimplantation Genetic Screening (PGS) Technology Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

The global Preimplantation Genetic Screening (PGS) Technology Market study covers all the growth prospects of the market along with the forecast trends. The report also covers other essential factors including market valuation, latest trends, growth influencers, restraints, and opportunities. The global Preimplantation Genetic Screening (PGS) Technology market report provides the market share, size, revenue, and growth of each segment. The research report demonstrates the segment-wise study of the Preimplantation Genetic Screening (PGS) Technology industry through the market statistics and evolving market dynamics.

Data provided by Extent Research. Source: https://www.extentresearch.com/preimplantation-genetic-screening-pgs-technology-market

Enticingly, the global Preimplantation Genetic Screening (PGS) Technology report covers a section dedicated to competitive landscape that clearly explains the top players status, share, revenue, manufacturing process, new product launches, and various business strategies that will have an influence on the market growth during the forecast period. Some of the key players in the Preimplantation Genetic Screening (PGS) Technology market include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology, INVICTA, Genea, Progenesis, Igenomix, Reproductive Health and Wellness Center, .

Segmentation of the Global Preimplantation Genetic Screening (PGS) Technology Market:

By Product type

  • Next-generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-nucleotide Polymorphism,

by Application

  • Maternity Centers & Fertility Clinics, Hospitals, Research Laboratories & Academic Institutes, Others,

The report also outlines the regional development status of the global Preimplantation Genetic Screening (PGS) Technology market and it also throws light on the supply & demand chain, profits, and market attractiveness in the various regions. Some of most established regions include North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Preimplantation Genetic Screening (PGS) Technology Report Provides Vital Information Including:

  • Company profile, business strategies, revenue gains, and market competitiveness
  • Changing market dynamics based on the market segments
  • Statistical and analytical market growth assessment
  • Evolving consumption and sales trends of each market segment
  • Historical and forecast trends of the global Preimplantation Genetic Screening (PGS) Technology market

Research Report Provides Answers To Few Key Questions Like:

  • What are the factors expected to enhance the Preimplantation Genetic Screening (PGS) Technology market growth rate?
  • Which are regions expected to show market growth during the forecast period?
  • Which are historical and future trends likely to influence the growth of the Preimplantation Genetic Screening (PGS) Technology market?
  • Which are major players dominating the Preimplantation Genetic Screening (PGS) Technology market?
  • What is the USP for the global attractiveness of Preimplantation Genetic Screening (PGS) Technology market?
  • What are the opportunities and challenges that increase the growth prospects of the market?
  • Which is most preferred growth strategy adopted by the competitive players?
  • What are risks likely to restrain the market growth?

Report Scope and Market Segmentation

ATTRIBUTES Global Preimplantation Genetic Screening (PGS) Technology Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M

Industry Related Reports

Smart Diapers Market Advance Directive Market DKK-1 Biomarker Market Global Anti Hepatitis Virus Drugs Market Global Mecobalamin Market Global Intraoperative Monitoring (IOM) Solutions Market
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Preimplantation Genetic Screening (PGS) Technology Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 Next-generation Sequencing 1.2.3 Polymerase Chain Reaction 1.2.4 Fluorescence in Situ Hybridization 1.2.5 Comparative Genomic Hybridization 1.2.6 Single-nucleotide Polymorphism 1.3 Market by Application 1.3.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Maternity Centers & Fertility Clinics 1.3.3 Hospitals 1.3.4 Research Laboratories & Academic Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Perspective (2017-2035) 2.2 Preimplantation Genetic Screening (PGS) Technology Growth Trends by Region 2.2.1 Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2017 VS 2021 VS 2035 2.2.2 Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Region (2017-2022) 2.2.3 Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Region (2023-2035) 2.3 Preimplantation Genetic Screening (PGS) Technology Market Dynamics 2.3.1 Preimplantation Genetic Screening (PGS) Technology Industry Trends 2.3.2 Preimplantation Genetic Screening (PGS) Technology Market Drivers 2.3.3 Preimplantation Genetic Screening (PGS) Technology Market Challenges 2.3.4 Preimplantation Genetic Screening (PGS) Technology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue 3.1.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue (2017-2022) 3.1.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Players (2017-2022) 3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Preimplantation Genetic Screening (PGS) Technology Revenue 3.4 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio 3.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Screening (PGS) Technology Revenue in 2021 3.5 Preimplantation Genetic Screening (PGS) Technology Key Players Head office and Area Served 3.6 Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service 3.7 Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Type 4.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Type (2017-2022) 4.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2023-2035) 5 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Application 5.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Application (2017-2022) 5.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2023-2035) 6 North America 6.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size (2017-2035) 6.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type 6.2.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2017-2022) 6.2.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2023-2035) 6.2.3 North America Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2017-2035) 6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application 6.3.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2017-2022) 6.3.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2023-2035) 6.3.3 North America Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2017-2035) 6.4 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country 6.4.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2017-2022) 6.4.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2023-2035) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size (2017-2035) 7.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type 7.2.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2017-2022) 7.2.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2023-2035) 7.2.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2017-2035) 7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application 7.3.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2017-2022) 7.3.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2023-2035) 7.3.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2017-2035) 7.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country 7.4.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2017-2022) 7.4.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2023-2035) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size (2017-2035) 8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type 8.2.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2023-2035) 8.2.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2017-2035) 8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application 8.3.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2023-2035) 8.3.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2017-2035) 8.4 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region 8.4.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2023-2035) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size (2017-2035) 9.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type 9.2.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2017-2022) 9.2.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2023-2035) 9.2.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2017-2035) 9.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application 9.3.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2017-2022) 9.3.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2023-2035) 9.3.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2017-2035) 9.4 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country 9.4.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2017-2022) 9.4.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2023-2035) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size (2017-2035) 10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type 10.2.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2023-2035) 10.2.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Type (2017-2035) 10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application 10.3.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2023-2035) 10.3.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Application (2017-2035) 10.4 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country 10.4.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2023-2035) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Illumina 11.1.1 Illumina Company Details 11.1.2 Illumina Business Overview 11.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Introduction 11.1.4 Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.1.5 Illumina Recent Developments 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Introduction 11.2.4 Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.2.5 Thermo Fisher Scientific Recent Developments 11.3 Agilent Technologies 11.3.1 Agilent Technologies Company Details 11.3.2 Agilent Technologies Business Overview 11.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Introduction 11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.3.5 Agilent Technologies Recent Developments 11.4 PerkinElmer 11.4.1 PerkinElmer Company Details 11.4.2 PerkinElmer Business Overview 11.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Introduction 11.4.4 PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.4.5 PerkinElmer Recent Developments 11.5 Coopersurgical 11.5.1 Coopersurgical Company Details 11.5.2 Coopersurgical Business Overview 11.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Introduction 11.5.4 Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.5.5 Coopersurgical Recent Developments 11.6 Natera 11.6.1 Natera Company Details 11.6.2 Natera Business Overview 11.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Introduction 11.6.4 Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.6.5 Natera Recent Developments 11.7 Takara Bio 11.7.1 Takara Bio Company Details 11.7.2 Takara Bio Business Overview 11.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Introduction 11.7.4 Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.7.5 Takara Bio Recent Developments 11.8 Oxford Gene Technology 11.8.1 Oxford Gene Technology Company Details 11.8.2 Oxford Gene Technology Business Overview 11.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Introduction 11.8.4 Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.8.5 Oxford Gene Technology Recent Developments 11.9 INVICTA 11.9.1 INVICTA Company Details 11.9.2 INVICTA Business Overview 11.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Introduction 11.9.4 INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.9.5 INVICTA Recent Developments 11.10 Genea 11.10.1 Genea Company Details 11.10.2 Genea Business Overview 11.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Introduction 11.10.4 Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.10.5 Genea Recent Developments 11.11 Progenesis 11.11.1 Progenesis Company Details 11.11.2 Progenesis Business Overview 11.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Introduction 11.11.4 Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.11.5 Progenesis Recent Developments 11.12 Igenomix 11.12.1 Igenomix Company Details 11.12.2 Igenomix Business Overview 11.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Introduction 11.12.4 Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.12.5 Igenomix Recent Developments 11.13 Reproductive Health and Wellness Center 11.13.1 Reproductive Health and Wellness Center Company Details 11.13.2 Reproductive Health and Wellness Center Business Overview 11.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Introduction 11.13.4 Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2017-2022) 11.13.5 Reproductive Health and Wellness Center Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Browse Related Pages

Global Preimplantation Genetic Screening (PGS) Technology Market Companies More Medical Care Reports

Have Questions?

Speak to our analysts to get answers to your queries.

Inquiry Before Buying
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/preimplantation-genetic-screening-pgs-technology-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/preimplantation-genetic-screening-pgs-technology-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors